Le Lézard
Classified in: Environment, Health
Subject: ENVIRONMENTAL NEWS

Solis Tek Applauds California Pesticide Ban for Cannabis Cultivation


CARSON, CA--(Marketwired - January 22, 2018) - Solis Tek Inc. (OTCQB: SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S, today commented on the California Bureau of Medical Cannabis Regulation's new regulations announced on January 1, 2018, banning the use of a long list of pesticides in cannabis cultivation for medical and adult-use industries. This list represents the most stringent in the country to protect users from ingesting cannabis with harsh chemicals, heavy metals and other properties.

"Solis Tek applauds the California Bureau of Medical Cannabis Regulation and encourages other governing bodies in states with adult- and medical-use laws in place to take the same responsible look at how flower is being cultivated with an eye toward protecting consumers," said Dennis G. Forchic, Chief Executive Officer of Solis Tek.

Mr. Forchic continued, "Having served this industry for nearly a decade, Solis Tek recognizes there is a better way for cultivators to increase yield, protect their crops, enhance their product and ultimately grow healthier plants. This is possible using all-natural products made with organic compounds that are devoid of any banned pesticides, animal by-products, heavy metals, chemicals, or strong odors. These are the types of products that Solis Tek is committed to creating to serve the growing cannabis sector, which is projected to reach $3.7 billion in 2018 in California alone."

"In response to welcomed changes in regulations in various states like that of California and the anticipated tightening of regulations as more states legalize cannabis, our Zelda Horticulture division is developing rigorously tested, all-natural products that provide new and alternative solutions to many of the banned products which have been previously utilized by cannabis cultivators. For example, our first product, Terpenez, provides a safe, effective and regulatory-compliant solution for growers in legal markets both in the U.S. and internationally to enhance their plants' terpene profile," Mr. Forchic added.

Mr. Forchic concluded, "As a response to the new California ban, Solis Tek is aggressively targeting the hydroponic stores in the Golden state, most of which carry our lighting product solutions, that now are replacing banned products on their shelf. Retailers and commercial growers alike have made clear their desire for Solis Tek's products under development, in beta testing, and nearing national launch, all of which contain NONE of the California banned products."

To be added to the Solis Tek email distribution list, please email [email protected] with 'SLTK' in the subject line.

About Solis Tek
Solis Tek Inc, parent company of wholly owned subsidiaries Solis Tek Digital Lighting and Zelda Horticulture, is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. In late 2017, Solis Tek introduced Zelda Horticulture, an all-natural, heavy metals free, nutrient line. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, please visit our website, http://solis-tek.com.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


These press releases may also interest you

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...



News published on and distributed by: